The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Open accessAbstract
Objective: To investigate and compare the prevalence, comorbidities and management of gout in practice in the UK and Germany. Methods: A retrospective analysis of patients with gout, identified through the records of 2.5 million patients in UK general practices and 2.4 million patients attending GPs or internists in Germany, using the IMS Disease Analyzer. Results: The prevalence of gout was 1.4% in the UK and Germany. Obesity was the most common comorbidity in the UK (27.7%), but in Germany the most common comorbidity was diabetes (25.9%). The prevalence of comorbidities tended to increase with serum uric acid (sUA) levels. There was a positive correlation between sUA level and the frequency of gout flares. Compared with those in whom sUA was <360 μmol/l (<6 mg/dl), odds ratios for a gout flare were 1.33 and 1.37 at sUA 360–420 μmol/l (6–7 mg/dl), and 2.15 and 2.48 at sUA >530 μmol/l ( >9 mg/dl) in the UK and Germany, respectively (p<0.01). Conclusions: The prevalence of gout in practice in the UK and Germany in the years 2000–5 was 1.4%, consistent with previous UK data for 1990–9. Chronic comorbidities were common among patients with gout and included conditions associated with an increased risk for cardiovascular disease, such as obesity, diabetes and hypertension. The importance of regular monitoring of sUA in order to tailor gout treatment was highlighted by data from this study showing that patients with sUA levels ⩾360 μmol/l (⩾6 mg/dl) had an increased risk of gout flares.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current estimates from the National Health Interview Survey.
Ss, J. (1981) · PubMed · Cited by 1,866
National Center for Health Statistics ( NCHS )
Feinleib, M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a16042 · Cited by 1,574
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Self-citationIs There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Current estimates from the National Health Interview Survey, 1990.
Adams, P. F., Hendershot, G. E., & Marano, M. A. (1987) · PubMed · Cited by 1,104
Choi, H. K., Mount, D. B., & Reginato, A. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00009 · Cited by 942
Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Hande, K. R., Noone, R. M., & Stone, W. J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90743-5 · Cited by 680
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century
Symmons, D. (2002) · Rheumatology · doi:10.1093/rheumatology/41.7.793 · Cited by 646
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F., & Nichol, M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 633
Choi, H. K., Atkinson, K., Karlson, E. W., & Curhan, G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.742 · Cited by 625
Zhang, W., Doherty, M., Pascual, E., Bardin, T., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055251 · Cited by 584
Self-citationJordan, K. M., Cameron, J. S., Snaith, M., Zhang, W., Doherty, M., Seckl, J., Hingorani, A., Jaques, R., & Nuki, G. (2007) · Rheumatology · doi:10.1093/rheumatology/kem056a · Cited by 552
Self-citationChoi, H. K., Ford, E. S., Li, C., & Curhan, G. (2007) · Arthritis Care & Research · doi:10.1002/art.22466 · Cited by 463
Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout
Perez‐Ruiz, F., Calabozo, M., Pijoan, J. I., Herrero‐Beites, A. M., & Ruibal, A. (2002) · Arthritis Care & Research · doi:10.1002/art.10511 · Cited by 454
Shoji, A., Yamanaka, H., & Kamatani, N. (2004) · Arthritis Care & Research · doi:10.1002/art.20405 · Cited by 438
Gout epidemiology: results from the UK General Practice Research Database, 1990–1999
Mikuls, T. R., Farrar, J. T., Bilker, W. B., Fernandes, S., Schumacher, H. R., & Saag, K. G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.024091 · Cited by 433
Gout and the risk of acute myocardial infarction
Krishnan, E., Baker, J. F., Furst, D. E., & Schumacher, H. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22014 · Cited by 430
Wallace, K. L., Riedel, A. A., Joseph‐Ridge, N., & Wortmann, R. L. (2004) · PubMed · Cited by 426
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Li‐Yu, J., Clayburne, G. M., Sieck, M. S., Beutler, A. M., Rull, M., Eisner, E. V., & Schumacher, H. R. (2001) · PubMed · Cited by 193
Serum Urate Levels and Gout Flares: Analysis From Managed Care Data
Sarawate, C. A., Patel, P. A., Schumacher, H. R., Yang, W., Brewer, K. K., & Bakst, A. W. (2006) · JCR: Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000209882.50228.9f · Cited by 186
Pascual, E. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340203 · Cited by 180
Gout: a clinical and radiologic review
Monu, J. U. V., & POPE, T. L. (2004) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(03)00158-1 · Cited by 153
The prevalence and prophylaxis of gout in England
Harris, C. M., Lloyd, D. C. E. F., & Lewis, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00244-k · Cited by 146
Roubenoff, R. (1990) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00887-5 · Cited by 126
Elliott, W. J. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70013-8 · Cited by 67
Riedel, A. A., Nelson, M., Wallace, K. L., Joseph‐Ridge, N., Cleary, M., & Fam, A. G. (2004) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000147049.12220.32 · Cited by 66
Gout, not induced by diuretics? A case-control study from primary care
Janssen, M., van de Lisdonk, E. H., Janssen, M., van den Hoogen, H. J. M., & Verbeek, A. L. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.040360 · Cited by 53
Cited by
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Self-citationGlobal epidemiology of gout: prevalence, incidence and risk factors
Kuo, C.-F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.91 · Cited by 1,179
Richette, P., & Bardin, T. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60883-7 · Cited by 915
Gabriel, S. E., & Michaud, K. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2669 · Cited by 891
Neogi, T., Jansen, T. L. T. A., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., Brown, M., Choi, H., Edwards, N. L., Janssens, H. J. E. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208237 · Cited by 888
Self-citation
Metadata
- Authors
- Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V, Gilbert, T., & Nuki, G.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 67
- Issue
- 7
- Pages
- 960-966
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2131879291
- Cited by
- 495
- References
- 30
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.